STEREOSELECTIVE PHARMACOKINETICS OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS IN PREGNANT SHEEP

Alfaro, 2000, CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations., J Clin Pharmacol, 40, 58, 10.1177/009127000004000108

Bergstrom, 1988, Clinical pharmacology and pharmacokinetics of fluoxetine: a review., Br J Psychiatry, 47, 10.1192/S0007125000297286

Cabrera-Vera, 1998, Prenatal exposure to fluoxetine (Prozac) produces site-specific and age-dependent alterations in brain serotonin transporters in rat progeny: evidence from autoradiographic studies., J Pharmacol Exp Ther, 286, 1474, 10.1016/S0022-3565(24)37746-8

Catterson, 1996, Pharmacokinetics of selective serotonin reuptake inhibitors: clinical relevance., Pharmacol Toxicol, 78, 203, 10.1111/j.1600-0773.1996.tb00206.x

Chambers, 1999, Weight gain in infants breastfed by mothers who take fluoxetine., Pediatrics, 104, e61, 10.1542/peds.104.5.e61

Chambers, 1996, Birth outcomes in pregnant women taking fluoxetine., N Engl J Med, 335, 1010, 10.1056/NEJM199610033351402

Chien, 1999, Chronic exposure and pharmacokinetics of fluoxetine and norfluoxetine enantiomers in the pregnant ewe and fetus., AAPS Pharm Sci, 1, S224

Clark, 1980, Effect of serotonin on uterine blood flow in pregnant and nonpregnant sheep., Life Sci, 27, 2655, 10.1016/0024-3205(80)90556-1

Cohen, 2000, Birth outcomes following prenatal exposure to fluoxetine., Biol Psychiatry, 48, 996, 10.1016/S0006-3223(00)00877-5

Daniel, 1997, Interactions between promazine and antidepressants at the level of cellular distribution., Pharmacol Toxicol, 81, 259, 10.1111/j.1600-0773.1997.tb00003.x

DeVane, 1999, Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors., Cell Mol Neurobiol, 19, 443, 10.1023/A:1006934807375

Di Pasquale, 1994, Endogenous serotonin modulates the fetal respiratory rhythm: an in vitro study in the rat., Brain Res Dev Brain Res, 80, 222, 10.1016/0165-3806(94)90107-4

Faber, 1983, 79

Fjordside, 1999, The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine., Pharmacogenetics, 9, 55, 10.1097/00008571-199902000-00008

Fuller, 1992, Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo., Neuropharmacology, 31, 997, 10.1016/0028-3908(92)90100-4

Galtier, 1996, Pharmacological basis for hepatic drug metabolism in sheep., Vet Res, 27, 363

Goldstein, 1995, Effect of third trimester fluoxetine exposure on the newborn., J Clin Psychopharmacol, 15, 417, 10.1097/00004714-199512000-00005

Gram, 1994, Fluoxetine., N Engl J Med, 331, 1354, 10.1056/NEJM199411173312008

Hamelin, 1996, The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin., Clin Pharmacol Ther, 60, 512, 10.1016/S0009-9236(96)90147-2

2001

Harding, 1983, Fetal and maternal influences on arterial oxygen levels in the sheep fetus., J Dev Physiol (Oxf), 5, 267

Hiemke, 2000, Pharmacokinetics of selective serotonin reuptake inhibitors., Pharmacol Ther, 85, 11, 10.1016/S0163-7258(99)00048-0

Hwang, 1980, Effects of chronic fluoxetine administration on serotonin metabolism., Res Commun Chem Pathol Pharmacol, 29, 79

Kim, 1995, Stereoselective determination of fluoxetine and norfluoxetine by gas chromatography with mass selective detection., Pharm Res (NY), 12, S22

Kim, 1996, Stereoselective pharmacokinetics of fluoxetine and norfluoxetine in the sheep., Pharm Res (NY), 13, S494

Kim, 1999, Comparison of fetal and neonatal fluoxetine and paroxetine exposure during the perinatal period in humans., AAPS Pharm Sci, 1, S96

Krishna, 2002, Clearance and disposition of indomethacin in chronically instrumented fetal lambs following a 3-day continuous intravenous infusion., J Pharm Pharmacol, 54, 801, 10.1211/0022357021779140

Kulin, 1998, Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors., JAMA (J Am Med Assoc), 279, 609, 10.1001/jama.279.8.609

Kumar, 1997, Estimation of trans-placental and non-placental diphenhydramine clearances in the fetal lamb: the impact of fetal first-pass hepatic uptake., J Pharmacol Exp Ther, 282, 617, 10.1016/S0022-3565(24)36861-2

Kumar, 2000, Disposition of valproic acid in maternal, fetal, and newborn sheep. II: metabolism and renal elimination., Drug Metab Dispos, 28, 857

Kwan, 1995, Blood volume restitution and growth in fetal lambs after acute hemorrhage., Am J Physiol, 269, R749

Lemberger, 1985, Fluoxetine: clinical pharmacology and physiologic disposition., J Clin Psychiatry, 46, 14

Lu, 1972, Partial purification of cytochrome P-450 and P-448 from rat liver microsomes., Biochem Biophys Res Commun, 46, 1334, 10.1016/S0006-291X(72)80121-9

Mhanna, 1997, Potential fluoxetine chloride (Prozac) toxicity in a newborn., Pediatrics, 100, 158, 10.1542/peds.100.1.158

Milne, 1993, Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in sheep., Drug Metab Dispos, 21, 1151

Morrison, 2002, Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status, and growth., Pediatr Res, 51, 433, 10.1203/00006450-200204000-00007

Newport, 2001, Antidepressants during pregnancy and lactation: defining exposure and treatment issues., Semin Perinatol, 25, 177, 10.1053/sper.2001.24901

Nordeng, 2001, Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors., Acta Paediatr, 90, 288, 10.1080/080352501300067596

Nulman, 1997, Neurodevelopment of children exposed in utero to antidepressant drugs., N Engl J Med, 336, 258, 10.1056/NEJM199701233360404

Oberlander, 2002, Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response., Pediatr Res, 51, 443, 10.1203/00006450-200204000-00008

Olsen, 1988, Accumulation and clearance of morphine-3-β-D-glucuronide in fetal lambs., J Pharmacol Exp Ther, 247, 576

Pacifici, 1992, Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences., Clin Pharmacokinet, 23, 449, 10.2165/00003088-199223060-00005

Pastuszak, 1993, Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)., JAMA (J Am Med Assoc), 269, 2246, 10.1001/jama.1993.03500170076037

Pohland, 1989, Placental transfer and fetal distribution of fluoxetine in the rat., Toxicol Appl Pharmacol, 98, 198, 10.1016/0041-008X(89)90225-1

Riggs, 1988, Metoclopramide pharmacokinetics in pregnant and nonpregnant sheep., J Pharm Sci, 77, 373, 10.1002/jps.2600770502

Riggs, 1991, Tissue distribution of metoclopramide (MCP) in pregnant sheep., Pharm Res (NY), 8, S284

Ring, 1999, Fetal hepatic drug elimination., Pharmacol Ther, 84, 429, 10.1016/S0163-7258(99)00046-7

Rurak, 1991, Drug disposition and effects in the fetus., J Dev Physiol (Oxf), 15, 33

Spencer, 1993, Fluoxetine hydrochloride (Prozac) toxicity in a neonate., Pediatrics, 92, 721, 10.1542/peds.92.5.721

Stevens, 1993, Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450., J Pharmacol Exp Ther, 226, 964

Urichuk, 1997, Determination of p-nitrofluoromethylphenol, a metabolite of fluoxetine, in tissues and body fluids using an electron-capture gas chromatographic procedure., J Chromatogr Biomed Appl, 698, 103, 10.1016/S0378-4347(97)00304-6

von Moltke, 1997, Human cytochromes mediating N-demethylation of fluoxetine in vitro., Psychopharmacology (Berl), 132, 402, 10.1007/s002130050362

Vorhees, 1994, A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats., Fundam Appl Toxicol, 23, 194, 10.1006/faat.1994.1098

Wadelius, 1997, Induction of CYP2D6 in pregnancy., Clin Pharmacol Ther, 62, 400, 10.1016/S0009-9236(97)90118-1

Wang, 1985, Distribution and fate of acetaminophen conjugates in fetal lambs in utero., J Pharmacol Exp Ther, 235, 302

Wilkinson, 1975, Commentary: a physiological approach to hepatic drug clearance., Clin Pharmacol Ther, 18, 377, 10.1002/cpt1975184377

Wisner, 1993, Tricyclic dose requirements across pregnancy., Am J Psychiatry, 150, 1541, 10.1176/ajp.150.10.1541

Wong, 1990, Fluoxetine and its two enantiomers as selective serotonin reuptake inhibitors., Acta Pharm Nord, 2, 171

Wright, 1991, Clearance and disposition of ritodrine in the fluid compartments of the fetal lamb during and after constant rate fetal intravenous infusion., J Pharmacol Exp Ther, 258, 897

Yeleswaram, 1993, Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration., J Pharmacol Exp Ther, 267, 425

Yoo, 1986, Placental transfer of diphenhydramine in chronically instrumented pregnant sheep., J Pharm Sci, 75, 685, 10.1002/jps.2600750714